370 related articles for article (PubMed ID: 16531505)
1. Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors.
Dong M; Pinon DI; Asmann YW; Miller LJ
Mol Pharmacol; 2006 Jul; 70(1):206-13. PubMed ID: 16531505
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor.
Miller LJ; Dong M; Harikumar KG; Gao F
Biochem Soc Trans; 2007 Aug; 35(Pt 4):709-12. PubMed ID: 17635130
[TBL] [Abstract][Full Text] [Related]
3. Class B GPCRs: a hidden agonist within?
Beinborn M
Mol Pharmacol; 2006 Jul; 70(1):1-4. PubMed ID: 16632645
[TBL] [Abstract][Full Text] [Related]
4. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
Park CG; Ganguli SC; Pinon DI; Hadac EM; Miller LJ
J Pharmacol Exp Ther; 2000 Nov; 295(2):682-8. PubMed ID: 11046106
[TBL] [Abstract][Full Text] [Related]
5. Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor.
Dong M; Lam PC; Gao F; Hosohata K; Pinon DI; Sexton PM; Abagyan R; Miller LJ
Mol Pharmacol; 2007 Aug; 72(2):280-90. PubMed ID: 17475809
[TBL] [Abstract][Full Text] [Related]
6. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
[TBL] [Abstract][Full Text] [Related]
7. Molecular approximation between residue 10 of secretin and its receptor demonstrated by photoaffinity labeling.
Dong M; Miller LJ
Ann N Y Acad Sci; 2006 Jul; 1070():243-7. PubMed ID: 16888174
[TBL] [Abstract][Full Text] [Related]
8. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
Ozcelebi F; Holtmann MH; Rentsch RU; Rao R; Miller LJ
Mol Pharmacol; 1995 Nov; 48(5):818-24. PubMed ID: 7476911
[TBL] [Abstract][Full Text] [Related]
9. Use of photoaffinity labeling to understand the molecular basis of ligand binding to the secretin receptor.
Dong M; Miller LJ
Ann N Y Acad Sci; 2006 Jul; 1070():248-64. PubMed ID: 16888175
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor.
Holtmann MH; Hadac EM; Ulrich CD; Miller LJ
J Pharmacol Exp Ther; 1996 Nov; 279(2):555-60. PubMed ID: 8930157
[TBL] [Abstract][Full Text] [Related]
11. Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors.
Harikumar KG; Morfis MM; Lisenbee CS; Sexton PM; Miller LJ
Mol Pharmacol; 2006 Jan; 69(1):363-73. PubMed ID: 16244179
[TBL] [Abstract][Full Text] [Related]
12. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis.
Ganguli SC; Park CG; Holtmann MH; Hadac EM; Kenakin TP; Miller LJ
J Pharmacol Exp Ther; 1998 Aug; 286(2):593-8. PubMed ID: 9694908
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization and purification of the secretin receptor expressed in baculovirus-infected insect cells.
Asmann YW; Dong M; Miller LJ
Regul Pept; 2004 Dec; 123(1-3):217-23. PubMed ID: 15518915
[TBL] [Abstract][Full Text] [Related]
14. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
[TBL] [Abstract][Full Text] [Related]
15. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
Dong M; Liu G; Pinon DI; Miller LJ
Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
[TBL] [Abstract][Full Text] [Related]
16. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
17. Informed development of drugs acting at family B G protein-coupled receptors.
Miller LJ
Ann N Y Acad Sci; 2008 Nov; 1144():203-9. PubMed ID: 19076378
[TBL] [Abstract][Full Text] [Related]
18. Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.
Dong M; Lam PC; Pinon DI; Sexton PM; Abagyan R; Miller LJ
Mol Pharmacol; 2008 Aug; 74(2):413-22. PubMed ID: 18467541
[TBL] [Abstract][Full Text] [Related]
19. Refinement of the pharmacophore of an agonist ligand of the secretin receptor using conformationally constrained cyclic hexapeptides.
Dong M; Narang P; Pinon DI; Bordner AJ; Miller LJ
Peptides; 2010 Jun; 31(6):1094-8. PubMed ID: 20214947
[TBL] [Abstract][Full Text] [Related]
20. The orthosteric agonist-binding pocket in the prototypic class B G-protein-coupled secretin receptor.
Miller LJ; Dong M
Biochem Soc Trans; 2013 Feb; 41(1):154-8. PubMed ID: 23356276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
